Risk Evaluation and Mitigation Strategies: Modifications and Revisions Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 9, 2019
June 29, 2020
97c2bcd1-cfbd-4928-92c1-d3ac287909b5
Related Documents
Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry
Guidance DocumentAugust 5, 2020Center for Drug Evaluation and Research
Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff
Guidance DocumentNovember 24, 2020Center for Drug Evaluation and Research
Q2(R2) Validation of Analytical Procedures
Guidance DocumentMarch 6, 2024Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox